Scinai Immunotherapeutics just reported results for the first quarter of 2024. More
Articles
3 High-Momentum Stocks That Are Way Cheaper Than Nvidia
Nvidia stock isn't the only play out there for growth investors seeking high-momentum stocks to finish out the year strong. More
3 High-Growth Cryptos Worth Speculating On Now
These three high-growth cryptocurrencies certainly seem like compelling bets for investors looking to capitalize on the growth of this sector. More
3 Cannabis Stocks Worth Having High Hopes For
Explore promising cannabis stocks poised for growth as the industry expands globally, driven by new product innovations. More
RDUS Stock Earnings: Radius Recycling Beats EPS, Misses Revenue for Q3 2024
RDUS stock results show that Radius Recycling beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024. More
3 Hydrogen Stocks to Buy for 10x Upside Potential in July 2024
Here are three hydrogen stocks long-term investors may want to look at for higher-risk, higher upside gains during this point in the cycle. More
The 3 Best Dividend Growth Stocks to Buy in July 2024
Explore promising dividend growth stocks for July 2024, including UnitedHealth Group, Automatic Data Processing, and Moody's Corporation. More
